Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Breast: Page 451
Fischer sells remaining businesses, files Chapter 11
By
AuntMinnie.com staff writers
Fischer Imaging of Denver said that it has signed a definitive agreement to sell its radiology, electrophysiology, and surgical (RE&S) business to contract manufacturer Byers Peak of Wheat Ridge, CO.
August 22, 2006
False negative for mammography resolved by tomosynthesis
This woman had her regular screening mammogram, which was rated as BI-RADS 1, or normal.
Some weeks later she returned because of a palpable lump in her breast. Ultrasound detected this lump and was determined through biopsy to be DCIS. Her mammogram was retrospectively reviewed and the cancer was deemed to be mammographically occult.
On review of the tomosynthesis image, taken at the same time as the mammogram, the cancer can be clearly seen near the skin line above the nipple.
This image is from a technology that is a work-in-progress and that does not have regulatory approval in certain global markets.
August 21, 2006
False positive for mammography resolved by tomosynthesis
An object on a conventional digital mammogram was highly suspicious for malignancy. The structure was seen in both the MLO and CC views, and persisted on the multiple diagnostic mammograms. The patient underwent biopsy and the structure was benign.
If you look at the corresponding tomosynthesis images, you see nothing malignant. The structure seen in the conventional mammogram was the result of overlapping tissues. Diagnosis was given as superimposed parenchyma.
At another height in the breast, a series of calcifications can be seen in the tomosynthesis cine loop. Because of the 3D nature of the tomosynthesis images, these are known to be within a few millimeters of the skin’s surface.
This image is from a technology that is a work-in-progress and that does not have regulatory approval in certain global markets.
August 21, 2006
Preop FDG-PET spots axillary involvement in breast cancer, may obviate biopsy
By
Shalmali Pal
Surgeons should consider breast PET studies to determine if they can skip biopsy and proceed straight to axillary lymph node dissection (AND), according to a study in the
Archives of Surgery
. But the study authors cautioned that the PET exam must predict positive nodes with 100% specificity.
August 20, 2006
Multimodality breast CAD workstation improves diagnostic performance
By
Erik L. Ridley
A computer-aided diagnosis (CAD) multimodality workstation can improve the performance of radiologists in differentiating malignant and benign breast lesions on mammography and sonography, according to research published in the August issue of
Radiology
.
August 16, 2006
NovaScan raises development capital
By
AuntMinnie.com staff writers
Breast cancer imaging start-up NovaScan has raised $285,000 in equity funding from investors, with another $100,000 available to it through grants and loans.
August 15, 2006
Digi-Solve unveils digital mammo fee-per-procedure offering
By
AuntMinnie.com staff writers
Outsource provider Digi-Solve has introduced a digital mammography fee-per-procedure program at a price point of $37.50 per exam, according to the Ponte Vedra Beach, FL-based firm.
August 14, 2006
NEMA publishes new FFDM QC standards
By
AuntMinnie.com staff writers
The National Electrical Manufacturers Association (NEMA) has published new test standards for the quality assurance plans of displays, workstations, and hard-copy output devices labeled for final interpretation in an full-field digital mammography (FFDM) system.
August 14, 2006
CMS proposes 54% cut in mammo CAD reimbursement
By
Cynthia E. Keen
The U.S. Centers for Medicare and Medicaid Services (CMS) has proposed a 54% cut to the technical compensation rate for the use of computer-aided detection (CAD) with digital and analog mammography, according to an analysis by the Stanford Washington Research Group in Washington, DC.
August 14, 2006
SLN procedure in pregnant breast cancer patients leads to negligible fetal dose
By
Shalmali Pal
Sentinel lymph node (SLN) biopsy and lymphoscintigraphy are becoming the standard of care for pregnant breast cancer patients. Fortunately, this radiocolloid-based technique doesn't pose significant risk to a fetus, according to research in the
Journal of Nuclear Medicine
.
August 13, 2006
Hologic completes FTC settlement
By
AuntMinnie.com staff writers
Women's imaging vendor Hologic of Bedford, MA, reported that the U.S. Federal Trade Commission (FTC) has given its final approval to a consent agreement regarding the acquisition of the Mammotest prone bed breast biopsy system from Denver-based Fischer Imaging last year.
August 9, 2006
New study analyzes digital mammography's workflow impact
By
Kate Madden Yee
A new study by researchers from Northwestern University in Chicago found that digital mammography proved to be more efficient in terms of acquisition time than film-screen mammography, while its interpretation time was longer per exam than for the analog studies.
August 9, 2006
Previous Page
Page 451 of 573
Next Page